Clinical Trial 41918

St. Charles, MO 63304


A phase ii multi-center, randomized, doubleblind, 24-week, parallel group, placebo-controlled study to investigate the efficacy and safety of balovaptan (ro5285119) in children and adolescents age 5-12 with autism spectrum disorder (asd).

Qualified Participants Must:

• 5-12 years old
• Be diagnosed with autism
• Have an IQ score of 70 or above
• Have some level of verbal fluency

Qualified Participants May Receive:

  1. Compensation
  2. Comprehensive autism evaluation by a physician
  3. Intelligence testing
  4. Labs
  5. Medications at no cost
  6. Potential inclusion in year long extension study

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.